Intelligent Bio Solutions Inc. Common Stock (INBS) is a publicly traded Healthcare sector company. As of July 21, 2026, INBS trades at $1.79 with a market cap of $5.05M and a P/E ratio of -0.92. INBS moved -4.57% today. Year to date, INBS is -51.95%; over the trailing twelve months it is -90.84%. Its 52-week range spans $1.90 to $27.50. Rallies surfaces INBS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for INBS, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $1.79 |
| Market Cap | $5.05M |
| P/E Ratio | -0.92 |
| EPS | $-2.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $27.50 |
| 52-Week Low | $1.90 |
| Volume | 239.48K |
| Avg Volume | 0 |
| Revenue (TTM) | $3.05M |
| Net Income | $-10.60M |
| Gross Margin | 40.85% |
INBS analyst coverage data. Average price target: $0.00.